A Lavole

Summary

Country: France

Publications

  1. pmc A phase II study of cisplatin with intravenous and oral vinorelbine as induction chemotherapy followed by concomitant chemoradiotherapy with oral vinorelbine and cisplatin for locally advanced non-small cell lung cancer
    Delphine Lerouge
    Deparment of Pneumology and Thoracic Oncology, Centre Hospitalier Universitaire de Caen, France
    BMC Cancer 14:231. 2014
  2. doi request reprint [Lung cancer and HIV infection]
    A Lavole
    Service de Pneumologie et Reanimation, Hopital Tenon, Assistance Publique Hopitaux de Paris, 4, rue de la Chine, 75020 Paris, France Equipe de Recherche 2 et GRC UPMC 04 Theranoscan, Universite Pierre et Marie Curie, Universite Paris VI, 75006 Paris, France Electronic address
    Rev Mal Respir 31:133-41. 2014
  3. doi request reprint Routine administration of a single dose of cisplatin ≥ 75 mg/m2 after short hydration in an outpatient lung-cancer clinic
    Armelle Lavole
    Hopital Tenon, AP HP, département de pneumologie et réanimation respiratoire, Unité fonctionnelle d oncologie thoracique, Paris, France
    Bull Cancer 99:E43-8. 2012
  4. doi request reprint Effect of highly active antiretroviral therapy on survival of HIV infected patients with non-small-cell lung cancer
    Armelle Lavole
    Service de Pneumologie et Reanimation, Hopital Tenon, APHP and Faculté de Médecine Pierre et Marie Curie, Universite Paris VI, Paris, France
    Lung Cancer 65:345-50. 2009
  5. ncbi request reprint [Lung cancer in HIV-positive patients]
    A Lavole
    Service de Pneumologie et Reanimation Respiratoire, Hopital Tenon, AP HP, 4, rue de la Chine, 75970 Paris Cedex 20
    Rev Pneumol Clin 63:167-75. 2007
  6. doi request reprint [A simple view on lung cancer biology: the MET pathway]
    A M Ruppert
    Service de Pneumologie et Reanimation, Hopital Tenon, Assistance Publique Hopitaux de Paris, 4 rue de la Chine, Paris Cedex 20, France
    Rev Mal Respir 28:1241-9. 2011
  7. doi request reprint 2014 update on non-small cell lung cancer (excluding diagnosis)
    V Gounant
    Sorbonne Universités, UPMC Universite Paris 06, GRC n o 04, Theranoscan, 75252 Paris, France Service de pneumologie, Centre expert en oncologie thoracique et maladies pulmonaires rares, Hopital Tenon, AP HP, 4, rue de la Chine, 75020 Paris, France Service de chirurgie thoracique, Hopital Tenon, AP HP, 4, rue de la Chine, 75020 Paris, France Electronic address
    Diagn Interv Imaging 95:721-5. 2014
  8. ncbi request reprint [Predicting the response to chemotherapy in patients with non-small cell lung cancer]
    M Wislez
    Service de Pneumologie et de Réanimation, et d anatomie pathologique, Hopital Tenon, Université de Médecine Pierre et Marie Curie, Paris VI, France
    Rev Mal Respir 24:6S206-10. 2007
  9. ncbi request reprint [Therapeutic management of extensive bronchiolo-alveolar adenocarcinoma: chemotherapy or inhibitors of epidermal growth factor receptor tyrosine kinase?]
    J Cadranel
    Service de Pneumologie et Reanimation Respiratoire, Hopital Tenon, AP HP, 4, rue de la Chine, 75970 Paris Cedex 20
    Rev Pneumol Clin 63:147-54. 2007
  10. pmc Lung cancer in HIV infected patients: facts, questions and challenges
    J Cadranel
    Service de Pneumologie et Reanimation Respiratoire, Hopital Tenon, 4 rue de la Chine 75970, Paris Cedex 20, France
    Thorax 61:1000-8. 2006

Collaborators

Detail Information

Publications26

  1. pmc A phase II study of cisplatin with intravenous and oral vinorelbine as induction chemotherapy followed by concomitant chemoradiotherapy with oral vinorelbine and cisplatin for locally advanced non-small cell lung cancer
    Delphine Lerouge
    Deparment of Pneumology and Thoracic Oncology, Centre Hospitalier Universitaire de Caen, France
    BMC Cancer 14:231. 2014
    ..We conducted a phase II study to evaluate the efficacy and safety of fractionated oral vinorelbine with cisplatin as induction CT followed by CT-RT...
  2. doi request reprint [Lung cancer and HIV infection]
    A Lavole
    Service de Pneumologie et Reanimation, Hopital Tenon, Assistance Publique Hopitaux de Paris, 4, rue de la Chine, 75020 Paris, France Equipe de Recherche 2 et GRC UPMC 04 Theranoscan, Universite Pierre et Marie Curie, Universite Paris VI, 75006 Paris, France Electronic address
    Rev Mal Respir 31:133-41. 2014
    ..A phase II therapeutic trial (IFCT-CHIVA 1001) is under way nationally. ..
  3. doi request reprint Routine administration of a single dose of cisplatin ≥ 75 mg/m2 after short hydration in an outpatient lung-cancer clinic
    Armelle Lavole
    Hopital Tenon, AP HP, département de pneumologie et réanimation respiratoire, Unité fonctionnelle d oncologie thoracique, Paris, France
    Bull Cancer 99:E43-8. 2012
    ..The aim of this retrospective study was to confirm the safety of short hydration before giving an intermediate-to-high dose of cisplatin in an outpatient clinic...
  4. doi request reprint Effect of highly active antiretroviral therapy on survival of HIV infected patients with non-small-cell lung cancer
    Armelle Lavole
    Service de Pneumologie et Reanimation, Hopital Tenon, APHP and Faculté de Médecine Pierre et Marie Curie, Universite Paris VI, Paris, France
    Lung Cancer 65:345-50. 2009
    ..To evaluate the impact of highly active antiretroviral therapy (HAART) on survival in HIV infected patients with non-small-cell lung cancer (NSCLC)...
  5. ncbi request reprint [Lung cancer in HIV-positive patients]
    A Lavole
    Service de Pneumologie et Reanimation Respiratoire, Hopital Tenon, AP HP, 4, rue de la Chine, 75970 Paris Cedex 20
    Rev Pneumol Clin 63:167-75. 2007
    ..Prospective clinical studies are needed to define a better management strategy for lung cancer in HIV-positive patients...
  6. doi request reprint [A simple view on lung cancer biology: the MET pathway]
    A M Ruppert
    Service de Pneumologie et Reanimation, Hopital Tenon, Assistance Publique Hopitaux de Paris, 4 rue de la Chine, Paris Cedex 20, France
    Rev Mal Respir 28:1241-9. 2011
    ..In this review we discuss the structure of the MET receptor, the activated pathways, the main genomic anomalies in lung cancer and the development of MET inhibitors...
  7. doi request reprint 2014 update on non-small cell lung cancer (excluding diagnosis)
    V Gounant
    Sorbonne Universités, UPMC Universite Paris 06, GRC n o 04, Theranoscan, 75252 Paris, France Service de pneumologie, Centre expert en oncologie thoracique et maladies pulmonaires rares, Hopital Tenon, AP HP, 4, rue de la Chine, 75020 Paris, France Service de chirurgie thoracique, Hopital Tenon, AP HP, 4, rue de la Chine, 75020 Paris, France Electronic address
    Diagn Interv Imaging 95:721-5. 2014
    ..Clinical research in thoracic cancer is very active. The fight against tobacco should remain a priority...
  8. ncbi request reprint [Predicting the response to chemotherapy in patients with non-small cell lung cancer]
    M Wislez
    Service de Pneumologie et de Réanimation, et d anatomie pathologique, Hopital Tenon, Université de Médecine Pierre et Marie Curie, Paris VI, France
    Rev Mal Respir 24:6S206-10. 2007
    ..Data will be presented separately for patients with metastatic disease and for those where it is localized...
  9. ncbi request reprint [Therapeutic management of extensive bronchiolo-alveolar adenocarcinoma: chemotherapy or inhibitors of epidermal growth factor receptor tyrosine kinase?]
    J Cadranel
    Service de Pneumologie et Reanimation Respiratoire, Hopital Tenon, AP HP, 4, rue de la Chine, 75970 Paris Cedex 20
    Rev Pneumol Clin 63:147-54. 2007
    ..These observations point out the importance of further studies examining the proper strategy and to search for new compounds for the treatment of extensive ADC-BAC...
  10. pmc Lung cancer in HIV infected patients: facts, questions and challenges
    J Cadranel
    Service de Pneumologie et Reanimation Respiratoire, Hopital Tenon, 4 rue de la Chine 75970, Paris Cedex 20, France
    Thorax 61:1000-8. 2006
    ..Prospective clinical trials are needed to define the optimal detection and treatment strategies for lung cancer in HIV infected patients...
  11. ncbi request reprint [Other thoracic cancers. Bronchioloalveolar carcinoma and adenocarcinoma with bronchioloalveolar carcinoma feature: a clinico-pathological spectrum]
    J Cadranel
    Service de Pneumologie et de Reanimation Respiratoire, AP HP, Hopital Tenon, Faculte de Medecine Pierre et Marie Curie, Universite Paris VI, 4 rue de la Chine, Paris, France
    Rev Mal Respir 25:3S196-202. 2008
    ..However, the place of chemotherapy has recently been revisited...
  12. ncbi request reprint The role of skin toxicities in prolonged pemetrexed treatment: A case-control study
    A Ruppert
    Hopital Tenon, AP HP and Faculté de Médecine Pierre et Marie Curie, Universite Paris VI, Paris, France
    J Clin Oncol 29:e18025. 2011
    ..e., periorbital edema with conjunctivitis and edema of the limbs, leading to severe fluid retention, was diagnosed in our unit. The aim of this study was to evaluate the incidence and risk factors for CAEs...
  13. ncbi request reprint [Perioperative chemotherapy for early-stage disease: an extra chance for the patient?]
    B Milleron
    UF d Oncologie Thoracique, CancerEst, Service des Maladies Respiratoires, Hopital Tenon, Paris
    Rev Pneumol Clin 60:2S3-7. 2004
  14. ncbi request reprint [Treatment of non-small cell lung cancer (2003 update)]
    A Lavole
    Service de Pneumologie, Hopital Tenon, Paris, France
    Rev Mal Respir 21:175-8. 2004
  15. ncbi request reprint [Bronchioloalveolar carcinoma and adenocarcinoma with bronchioloalveolar features: a clinico-pathological spectrum]
    J Cadranel
    Service de Pneumologie et de Reanimation Respiratoire, AP HP, Hopital Tenon, Faculte de Medecine Pierre et Marie Curie, Universite Paris VI, France
    Rev Mal Respir 24:6S165-70. 2007
    ..However, the place of chemotherapy has recently been re-evaluated...
  16. doi request reprint [Association between thymic MALT lymphoma and Sjögren's syndrome]
    E Giroux Leprieur
    Unité fonctionnelle d oncologie thoracique, Service de Pneumologie et Reanimation Respiratoire, Hopital Tenon, 75020 Paris, France
    Rev Pneumol Clin 65:108-12. 2009
    ..Thymic mucosa-associated lymphoid tissue (MALT) lymphoma is a rare pathology, often associated with autoimmune diseases. The authors report the case of an Asian woman with Sjögren's syndrome...
  17. ncbi request reprint [Clinical types of thoracic cancer. Bronchiolo-alveolar carcinoma and adenocarcinoma with bronchioloalveolar features: a clinico-pathological spectrum]
    J Cadranel
    Service de Pneumologie et de Reanimation Respiratoire, AP HP, Hopital Tenon, Faculte de Medecine Pierre et Marie Curie, Universite Paris VI, 4, rue de la Chine, 75970 Paris Cedex 20
    Rev Mal Respir 23:16S158-16S163. 2006
    ..However, the place of chemotherapy has recently been reviewed...
  18. ncbi request reprint [Postoperative chemotherapy in non-small cell lung cancer]
    B Milleron
    UF d Oncologie Thoracique, Hopital Tenon, Cancer Est, Paris, France
    Rev Mal Respir 24:6S64-8. 2007
    ..For the stage IB, this survival increase is also probable, especially for the tumors higher than 4 cm. Several biologic markers are under investigation as predictors of the benefit of the chemotherapy...
  19. doi request reprint [A phase II study of cetuximab, pemetrexed, cisplatin, and concurrent radiotherapy in patients with locally advanced, unresectable, stage III, non squamous, non-small cell lung cancer (NSCLC)]
    J Tredaniel
    Unité de Cancérologie Thoracique, Hopital Saint Joseph, 185 rue Raymond Losserand, 75674 Paris Cedex 14, France
    Rev Mal Respir 28:51-7. 2011
    ..Cisplatin-based chemotherapy and concurrent radiotherapy are the standard treatments for locally advanced unresectable NSCLC. New therapeutic combinations using molecular targeted drugs are needed...
  20. ncbi request reprint Weekly paclitaxel combined with monthly carboplatin versus single-agent therapy in patients age 70 to 89: IFCT-0501 randomized phase III study in advanced non-small cell lung cancer (NSCLC)
    E A Quoix
    Hôopitaux Universitaires, Strasbourg, France Centre Hospitalier Louis Pasteur, Colmar, France Hôopital Universitaire, Besancon, France Service de pneumologie, CHU Bretonneau, Tours, France CHU Côote de Nacre, Caen, France IFCT, Paris, France Service de Pneumologie Hôopital Tenon, Paris, France Hopital Layne, Mont de Marsan, France Tenon University Hospital, Paris, France
    J Clin Oncol 28:2. 2010
    ..2 Background: Incidence of advanced NSCLC in the elderly is increasing. Specific trials for elderly are seldom and those patients are not optimally treated. Current recommendations are monotherapies with gemcitabine or vinorelbine...
  21. doi request reprint [Neurologic paraneoplastic syndrome with anti-CV2/CRMP5 antibodies revealing a small cell lung cancer. Effectiveness of the lung cancer treatment]
    L Rosencher
    Service de Pneumologie, Hopital Tenon, 4, rue de la Chine, 75970 Paris, France
    Rev Neurol (Paris) 168:371-4. 2012
    ..Various clinical manifestations can occur, cerebellar ataxia, polyneuropathy, optic neuritis with NORB or uveitis. Small cell lung carcinoma is generally responsible...
  22. ncbi request reprint [Lung cancer in patients with HIV infection: an emerging problem]
    A Lavole
    Service de Pneumologie, Hopital Tenon, 4 rue de la Chine, 75970 Paris Cedex 20, France
    Rev Pneumol Clin 60:4S39-4S43. 2004
  23. ncbi request reprint [Improved prognosis in non small cell lung cancer--myth or reality?]
    B Milleron
    Unité fonctionnelle d oncologie thoracique, Hôpital Tenon CancerEst, Paris, France
    Rev Mal Respir 22:8S137-42. 2005
    ..In conclusion, NSCLC survival can be improved in a selected population. To reproduce this in the whole population all patients should be managed in accordance with the results of recent trials...
  24. ncbi request reprint [Bevacizumab and invasive procedures: practical recommendations]
    V Gounant
    Service de Pneumologie et Reanimation Respiratoire, Hopital Tenon, AP HP, Universite Paris VI, Paris, France
    Rev Mal Respir 26:221-6. 2009
    ..Obviously, referral to a medico-surgical team experienced in the management of these patients is strongly recommended...
  25. ncbi request reprint Use of a three-microRNA signature to discriminate prognostic groups in early-stage NSCLC patients in the IFCT-0002 trial
    C Mascaux
    Division of Medical Oncology, University of Colorado Denver, Aurora, CO Caen University Hospital, Caen, France IFCT, Paris, France Tenon University Hospital, Paris, France Institut Jules Bordet, Brussels, Belgium Besançon University Hospital, Besancon, France Hôpital Tenon, AP HP and Faculté de Médecine Pierre et Marie Curie, Universite Paris VI, Paris, France Strasbourg University Hospital, Strasbourg, France Vesoul General Hospital, Vesoul, France University Hospital Larrey, Toulouse, France Montpellier University Hospital, Montpellier, France Grenoble University Hospital, Grenoble, France
    J Clin Oncol 29:7007. 2011
    ..peri-operative, and two regimens, CDDP-Gem vs. CBDCA-Pac (V. Westeel, ASCO 2009). We hypothesized that microRNA (miRNA) expression profile could discriminate prognostic groups in these patients...
  26. doi request reprint [Endobronchial lipoma: imaging findings. A case report]
    M Oury Bah
    Service de Radiologie, Hopital Tenon, AP HP, 4, rue de la Chine, and Universite Pierre et Marie Curie, 75020 Paris 20 e, France
    Rev Pneumol Clin 65:36-9. 2009
    ..The authors report MDCT and MR imaging in a patient with endobronchial lipoma discovered on an MDCT scan...